For patients with type 2 diabetes, there is an obvious feature, that number belongs to obese patients, in a sense, obesity control of the disease is a certain degree of influence, especially in the selection of drugs. Sulfonylurea and insulin therapy, for example, are caused by varying degrees of weight gain for overweight and obese patients, in principle, should be re-selection of these drugs, so as not to cause further increase in body weight, adverse long-term control of blood sugar.
Obesity is also a risk factor for cardiovascular disease, obese patients than in normal weight more easily complicated by other cardiovascular diseases such as hypertension, hyperlipidemia, coronary heart disease. Therefore, for obese type 2 diabetic patients, we should first consider the selection of biguanide drugs, such as metformin (Glucophage).
For patients with normal body weight control is equally important. Diabetes is a metabolic disorder, chronic diseases, the body fat, sugar metabolism has been greatly affected. Fat, abnormal glucose metabolism makes fat accumulation, the formation of overweight or obese, treatment and rehabilitation of patients with diabetes and its adverse. Patients with normal body should actively control their weight, while the more prominent role in this regard compared with other hypoglycemic agents metformin (Glucophage). Therefore, for normal-weight diabetic patients, metformin (Glucophage) is also regarded as a good choice.
Sulfonylurea and insulin can promote the conversion of glucose absorption, increase the effect of weight, slim body, patients can choose the sulfonylureas or other hypoglycemic agents combined insulin treatment.
In addition, Chinese medicine has its unique advantages in the treatment of diabetes, not only side effects is small, and can solve the problem of the effect, so patients can use multi-target medicine for the treatment of the fundamental.
